Chewing gum that traps COVID-19 particles in saliva to start human trials

Updated July 27 2022 - 12:19am, first published 12:03am
An experimental chewing gum may be able to reduce SARS-CoV-2 particles in saliva. (EPA PHOTO)

An experimental chewing gum that "traps" SARS-CoV-2 particles in saliva holds promise for curbing transmission of new variants of the virus, according to new data, as researchers prepare to launch the first human trial.



Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.